Vanguard Group’s Prelude Therapeutics PRLD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $754K | Sell |
|
|||||
|
2025
Q1 | $775K | Sell |
|
|||||
|
2024
Q4 | $1.29M | Sell |
|
|||||
|
2024
Q3 | $2.12M | Buy |
|
|||||
|
2024
Q2 | $3.85M | Sell |
|
|||||
|
2024
Q1 | $4.82M | Buy |
|
|||||
|
2023
Q4 | $4.3M | Buy |
|
|||||
|
2023
Q3 | $3.01M | Buy |
|
|||||
|
2023
Q2 | $4.29M | Buy |
|
|||||
|
2023
Q1 | $5.22M | Buy |
|
|||||
|
2022
Q4 | $5.43M | Buy |
|
|||||
|
2022
Q3 | $5.94M | Hold |
|
|||||
|
2022
Q2 | $4.69M | Buy |
|
|||||
|
2022
Q1 | $5.52M | Buy |
|
|||||
|
2021
Q4 | $9.6M | Sell |
|
|||||
|
2021
Q3 | $35.5M | Buy |
|
|||||
|
2021
Q2 | $32.2M | Buy |
|
|||||
|
2021
Q1 | $37.6M | Buy |
|
|||||
|
2020
Q4 | $47.2M | Buy |
|
|||||
|
2020
Q3 | $1.36M | Buy |
|